3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
33
Neoplasms
25
Prostatic Neoplasms
16
Colorectal Neoplasms
13
Lung Neoplasms
11
Multiple Myeloma
9
Head and Neck Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Hematologic Neoplasms
5
Gastrointestinal Neoplasms
5
Advanced Cancer
5
Uterine Cervical Neoplasms
4
Smoking Cessation
4
Ovarian Neoplasms
4
Melanoma
4
Leukemia
4
Colonic Neoplasms
4
Anxiety Disorders
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Neoplasms, Plasma Cell
3
Motor Activity
3
Lymphoma, Follicular
3
Lymphedema
3
Interventions
Gemcitabine
35
Cisplatin
21
Capecitabine
17
Oxaliplatin
16
Leucovorin
11
Fluorouracil
11
pembrolizumab
8
S 1 (combination)
8
Nivolumab
6
tremelimumab
5
durvalumab
5
Bevacizumab
5
lenvatinib
4
Irinotecan
4
trametinib
3
titanium silicide
3
atezolizumab
3
Radiofrequency Ablation
3
zanidatamab
2
vandetanib
2
irinotecan sucrosofate
2
derazantinib
2
camrelizumab
2
binimetinib
2
apatinib
2
Trastuzumab
2
Tegafur
2
Radiotherapy
2
Panitumumab
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Biliary Tract Neoplasms
×
Standard of Care
×
Clear all
NCT07184047
2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
72 enrolled